Quantification of changes in bone scans of patients with osseous metastases of prostatic carcinoma.
Prout
G R
GR
Department of Surgery, Harvard Medical School, Massachusetts General Hospital, Boston 02114.
Griffin
P P
PP
Castronovo
F P
FP
D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000556:secondary*; D002277:Carcinoma / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000556:secondary*; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology*; D011877:Radionuclide Imaging; D012074:Remission Induction; D013669:Technetium Tc 99m Medronate / Q000493:pharmacokinetics; D016896:Treatment Outcome
D006728:Hormones; D013669:Technetium Tc 99m Medronate